Pseudoephedrine Tide Turns: Nonprescription Sales Return In Mississippi, Oregon Mulls Change
Executive Summary
Mississippi repeals prescription requirement for all pseudoephedrine- and ephedrine-containing drugs while also requiring retailer participation in industry-funded technology for tracking drug sales. Oregon, the only other state with PSE Rx law, is considering repealing it.
You may also be interested in...
State Lawmakers Likely To Deal Questions About Oral Phenylephrine Into 2024 Legislation Deck
State government authority is limited to make changes concerning OTC sales, including oral products with phenylephrine. “As we've learned in the past, that hasn't stopped them before. We're going to be monitoring this very closely going into next year,” says CHPA state legislature lobby chief Carlos Gutierrez.
Pseudoephedrine Safety Review Initiated In EU Over Link To Neurological Problems
Reports of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome have triggered a European Union-wide safety review of pseudoephedrine.
Manufacturers Consider Design Changes For OTC Propylhexedrine Nasal Decongestant Inhalers
"Manufacturers are already working on possible solutions to address the concerns and will work with the Agency to implement any appropriate measures,” says CHPA senior VP Barbara Kochanowski.